NOTCH1 Aberrations in Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia

Published:2018-06-27 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Rosati Emanuela,Baldoni Stefano,De Falco Filomena,Del Papa Beatrice,Dorillo Erica,Rompietti Chiara,Albi Elisa,Falzetti Franca,Di Ianni Mauro,Sportoletti Paolo

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Associazione Italiana per la Ricerca sul Cancro

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference181 articles.

1. Chronic lymphocytic leukemia;Chiorazzi;N Engl J Med,2005

2. Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model;Baumann;Haematologica,2014

3. Chronic lymphocytic leukaemia;Kipps;Nat Rev Dis Primers,2017

4. The molecular pathogenesis of chronic lymphocytic leukaemia;Fabbri;Nat Rev Cancer,2016

5. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia;Rossi;Blood,2013

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies;International Journal of Molecular Sciences;2024-08-26

2. The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications;Exploration of Targeted Anti-tumor Therapy;2024-07-23

3. Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications;British Journal of Haematology;2024-06-21

4. BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism;Lymphatics;2024-03-28

5. Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course;Cancers;2024-03-08